| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,789,272 | $141,165,056 | $50.61 | 16 Oct 2024 | By Avalon BioVentures SPV I, LP |
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,115,373 | $94,662,942 | $44.75 | 18 Oct 2024 | By Avalon BioVentures SPV I, L.P. |
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,071,799 | $92,713,005 | $44.75 | 18 Oct 2024 | Direct |
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 401,321 | $17,959,115 | $44.75 | 18 Oct 2024 | By Avalon BioVentures I, LP |
| Janux Therapeutics, Inc. | 10%+ Owner | Stock Option (right to buy) | 6,072 | 17 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 16 Oct 2024 | 33 | -$77,250,361 | 4 | 10%+ Owner | 18 Oct 2024, 18:51 |
| JANX | Janux Therapeutics, Inc. | 26 Sep 2024 | 30 | -$14,404,133 | 4 | 10%+ Owner | 30 Sep 2024, 20:49 |
| JANX | Janux Therapeutics, Inc. | 10 Sep 2024 | 9 | -$21,153,619 | 4 | 10%+ Owner | 12 Sep 2024, 20:42 |
| JANX | Janux Therapeutics, Inc. | 06 Sep 2024 | 12 | -$10,134,526 | 4 | 10%+ Owner | 10 Sep 2024, 17:02 |
| JANX | Janux Therapeutics, Inc. | 03 Jun 2024 | 3 | -$82,125,000 | 4 | 10%+ Owner | 05 Jun 2024, 19:19 |
| JANX | Janux Therapeutics, Inc. | 29 Feb 2024 | 9 | $0 | 4 | 10%+ Owner | 04 Mar 2024, 19:31 |
| JANX | Janux Therapeutics, Inc. | 13 Nov 2023 | 1 | +$4,988,643 | 4 | 10%+ Owner | 13 Nov 2023, 19:11 |
| JANX | Janux Therapeutics, Inc. | 15 Jun 2021 | 11 | +$10,699,987 | 4 | 10%+ Owner | 16 Jun 2021, 17:59 |
| JANX | Janux Therapeutics, Inc. | 10 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 10 Jun 2021, 19:28 |